VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
ADTX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
ADTXAditxt, Inc.
$0.00$10
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
ADTX logo

Aditxt, Inc.

ADTX
NASDAQ · Immunology Biotech
$0.00
At close - Nov 6, 4:00 PM EST - USD
Market Cap$10
P/E-
52W High$1386.72
Volume1.2M
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2026Q1

Aditxt Faces Severe Liquidity and Solvency Crisis

Aditxt exhibits a fundamental collapse in its commercial diagnostic model, evidenced by quarterly revenue plummeting to a negligible $12,200. The company's reliance on massive stock-based compensation, which reached $472.8 million in 2025Q4, masks a severe underlying cash burn that threatens long-term viability.

GrowthContracting
ProfitabilityNegative
ValuationReview
TechnicalsWeak
Explore valuation models
MARKET ACTION

ADTX price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

No Data

No recent earnings data

02

Valuation risk

N/A

P/E data unavailable

03

Market leadership

N/A

RS data unavailable

04

Weak Trend

Below 200DMA

Price < 200DMA

Next CatalystConfirmed earnings · Dec 2

Market performance

Price History →

Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
ADTX-100.00%
S&P 500 (^GSPC)+7.63%
1-Year Return
ADTX-100.00%
S&P 500 (^GSPC)+9.69%
3-Year Return
ADTX-100.00%
S&P 500 (^GSPC)+68.57%
5-Year Return
ADTX-100.00%
S&P 500 (^GSPC)+49.77%

Growth & profitability

Annual revenue & EPS trend
Revenue FY25
$3K-97.6% YoY
Net income FY25
-$42M-21.1% YoY
Free cash flow FY25
-$25.7B-153234.4% YoY
Operating margin FY25
-612542.2%-591745.9 pts YoY
ROIC (FY25)-161.9%
Avg ROIC 5Y-262.8%
ROE (FY25)-681.6%
Piotroski Score3 / 9
Financial Statements →
04

Compare before deciding

Benchmark ADTX against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for Aditxt, Inc. (ADTX)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
ADTX logoADTXAditxt, Inc.Current
$0.00$10—-97.62%-362385.72%-681.6%—
IMMP logoIMMPImmutep Limited
$3.34$24.61M-0.45182.31%———
CRIS logoCRISCuris, Inc.
$0.91$1.77M-0.09-13.43%-490.33%-1035.26%—
AGEN logoAGENAgenus Inc.
$7.15$297.74M21.1910.37%20.98%——
NKTR logoNKTRNektar Therapeutics
$37.26$1.23B-7.84-43.89%-287.84%-37.99%—
AIMD logoAIMDAinos, Inc.
$0.70$5.15M-0.36498.95%-106283.32%-217.5%—

Compare ADTX vs Peers

Aditxt, Inc. (ADTX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs IMMP

Most directly comparable listed peer for ADTX.

Scale Benchmark

vs TMO

Larger-name benchmark to compare ADTX against a more recognizable public peer.

Peer Set

Compare Top 5

vs IMMP, CRIS, AGEN, NKTR

05

Keep researching

Verify the primary filings, follow material updates, and answer the remaining questions.

ADTX SEC Filings & Documents

Aditxt, Inc. (ADTX) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Jul 17, 2026·SEC

Material company update

Jun 24, 2026·SEC

Material company update

Jun 23, 2026·SEC

10-K Annual Reports

1
FY 2026

Mar 31, 2026·SEC

10-Q Quarterly Reports

3
FY 2026

May 20, 2026·SEC

FY 2025

Nov 18, 2025·SEC

FY 2025

May 15, 2025·SEC

Get notified when ADTX posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

ADTX Frequently Asked Questions

Aditxt, Inc. (ADTX) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Aditxt, Inc.'s revenue?

Aditxt, Inc. (ADTX) reported $0.0M in revenue over the trailing twelve months. Revenue was $0.0M in fiscal year 2025.

How fast is Aditxt, Inc. growing?

Aditxt, Inc. (ADTX) revenue fell by 74.1% over the trailing twelve months, compared with the twelve months before.

Is ADTX profitable?

No. Aditxt, Inc. (ADTX) reported a net loss of $52.0M over the trailing twelve months.

Dividend & Returns
What is ADTX's return on equity?

Aditxt, Inc. (ADTX) had a return on equity (ROE) of -681.6% in fiscal year 2025. A negative ROE means the company lost money over the period.

What is Aditxt, Inc.'s free cash flow?

Aditxt, Inc. (ADTX) had negative free cash flow of $18.6M over the trailing twelve months.

What if you invested $1,000 in ADTX back in 2017?

Total return calculator · dividends reinvested · 9+ years of data

See returns →